Matthew Q Reber, Partner at 1315 Capital, Philadelphia, Pennsylvania, United States — verified investor profile. See sector focus and contact routes.
Matthew Reber joined 1315 Capital as a Partner in 2017, bringing over two decades of growth-stage healthcare investing experience focused on pharma and medtech outsourcing and product sectors. The firm targets commercial-stage companies in healthcare services, medical technology, and therapeutics/pharma services, primarily within the United States. Reber has worked on more than $1 billion in healthcare financings and previously served as a Managing Director at HealthCare Royalty Partners. While specific check sizes and lead/follow behavior for Reber individually are not publicly detailed, 1315 Capital provides expansion and growth capital to commercial-stage firms. His notable board memberships include Coating Place, Codis, Experic, Medivant Healthcare, Primrose Bio, ProSciento, SciSafe, and USpharma, with prior board roles at Reaction Biology and Verogen. Reber holds a BSc in Engineering from Princeton, an MBA from Wharton, and a Master of Biotechnology from the University of Pennsylvania. No distinctive public writing or unique investment point of view beyond his sector focus is documented in available sources.
Every field above is read from the StartupFundraising investor directory — disclosed location, recorded investments and stated focus — and re-checked as filings arrive. Founders pair it with investors in Philadelphia when building a target list.
Investors like Matthew Q Reber · Full investor directory · Investor access · Company funding database